Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 52, n° 6
pages 1101-1102 (juin 2005)
Doi : 10.1016/j.jaad.2005.01.101
CASE NOTES

Alefacept in the treatment of psoriatic nail disease: A small case series
 

Christopher T. Cassetty, MD a, Andrew F. Alexis, MD, MPH a, Jerome L. Shupack, MD a, Bruce E. Strober, MD, PhD b,
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York 

Correspondence to: Bruce E. Strober, MD, PhD, Department of Dermatology, New York University, School of Medicine, TCH-158, 560 First Ave, New York, NY 10016
a  Drs Shupack and Alexis are speakers for Amgen-Wyeth.
b  Dr Strober is a speaker for Amgen-Wyeth, Biogen-Idec, Genentech, and Centocor.

Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@